Professor Paul Moss


Head of School of Cancer Sciences, Professor of Haematology


Contact details

School of Cancer Sciences
University of Birmingham
Cancer Sciences Building
B15 2TT


Professor Moss is Head of the School of Cancer Sciences at the University of Birmingham and Chairman of the Infection and Immunity Board at the Medical Research Council.  He served previously as Chair of the Cancer Research UK Clinical and Translational Research Committee.


List of qualifications to be added here


Biography information to be added here


Teaching Programmes
MBChB Year 5, MBChB Year 4, MBChB Year 3, MBChB Year 2, MBChB Year 1, BMedSci 3, BMedSci 2, BMedSci 1, Clinical Oncology MSc/PG Dip

Teaching Activity
Professor Moss makes substantial contributions to teaching at many levels, both within the University of Birmingham and beyond. He is currently Programme Director of the Intercalated Batchelor in Medical Sciences (Clinical Sciences) which offers medical students the opportunity to undertake an 8 month research project during their undergraduate degree. The course also has a dedicated programme of lecturers within the 6 themes of haematology, infection, histopathology, cancer studies, immunology and metabolic medicine.

Postgraduate supervision

Postgraduate supervision information to be added here


Research Themes
Cancer Cell Biology, Clinical Trials, Tumour Immunology and Immune/Gene Therapy, Viral Oncology

Research Activity

Professor Moss’s research is focussed around the application of translational immunological research in the study of human disease. His current research group includes clinical and non-clinical research scientists working on a range of different projects:

  • The role of cytomegalovirus infection in human health and disease
  • Mechanisms of graft-versus-leukaemia following stem cell transplantation
  • The immune response against cancers
  • The Immunology of pregnancy
  • The role of DARC mutation in the development of ethnic neutropenia

Other activities

Clinical Activity/NHS Affiliation
Professor Moss is an honorary consultant at the University Hospitals Birmingham NHS Foundation Trust. His primary interests are in haemato-oncology and general haematology and he is the Clinical Service Lead for chronic lymphocytic leukaemia.


MD Morgan, CJ Day, KP Piper, N Khan, L Harper, P Moss, COS Savage (2010) Patients with Wegener's granulomatosis demonstrate a relative deficiency and functional impairment of T-regulatory cells.

G Chakupurakal, D Onion, M Cobbold, V Mautner, P Moss (2009) Adenovirus vector-specific T cells demonstrate a unique memory phenotype with high proliferative potential and coexpression of CCR5 and integrin alpha4beta7

S Nicholls, KP Piper, F Mohammed, TR Dafforn, S Tenzer, M Salim, P Mahendra, CF Craddock, P van Endert, H Schild, M Cobbold, VH Engelhard, P Moss, BE Willcox (2009) Secondary anchor polymorphism in the HA-1 minor histocompatibility antigen critically affects MHC stability and TCR recognition
Proceedings of the National Academy of Sciences of the United States of America 106 3889-94

S Chidrawar, N Khan, W Wei, A McLarnon, N Smith, L Nayak, P Moss (2009) Cytomegalovirus-seropositivity has a profound influence on the magnitude of major lymphoid subsets within healthy individuals.
Clinical and experimental immunology 155 423-32

HM McGettrick, K Hunter, P Moss, CD Buckley, GE Rainger, GB Nash (2009) Direct observations of the kinetics of migrating T cells suggest active retention by endothelial cells with continual bidirectional migration
Journal of Leukocyte Biology 85 98-107


Cancer – especially immune response to cancer; immunity to viruses and related health problems; evolution in clinical medicine

Alternative contact number available for this expert: contact the press office

Back to top